腫瘍学・免疫学におけるフローサイトメトリー市場：タイプ、技術、製品・サービス、エンドユーザー別-2025-2030年の世界予測

腫瘍学・免疫学におけるフローサイトメトリー市場は、2023年に11億米ドルと評価され、2024年には11億8,000万米ドルに達すると予測され、CAGR 9.33％で成長し、2030年には20億6,000万米ドルになると予測されています。

フローサイトメトリーは、腫瘍学や免疫学で広く使用されている強力な分析技術であり、レーザービームを通過する細胞や粒子の物理的・化学的特性を測定します。これらの分野でのフローサイトメトリーの必要性は、異種細胞集団の表現型と機能を迅速にマルチパラメーター解析する能力によって強調され、病気の診断、予後、治療反応のモニタリングに役立っています。アプリケーションには、イムノフェノタイピング、細胞選別、がんバイオマーカー検出、細胞周期の状態判定などが含まれます。最終用途は、臨床検査室、学術研究機関、製薬会社、診断センターなど多岐にわたる。市場成長は主に、がんや免疫系疾患の有病率の増加、分析精度の向上と分析時間の短縮につながるフローサイトメトリー技術の進歩、薬力学や薬剤標的同定のような新規アプリケーションにおけるフローサイトメトリーの採用拡大によって影響を受けています。新たなビジネスチャンスは、フローサイトメトリー結果の速度と精度を高めることができるデータ解析のための人工知能の統合にあります。推奨事項としては、技術的アップグレードを活用すること、小規模ラボ向けのコスト効率の良いシステムを開発すること、ヘルスケアインフラが成長する未開拓市場に進出することなどが挙げられます。しかし、装置や試薬の高コスト、熟練した技術者の必要性、規制上の制約などの制約が、市場普及の課題となっています。データの比較可能性を確保するためのラボ間の標準化も、研究者や臨床医が直面する課題です。技術革新と研究に最適な分野としては、ポイントオブケア診断用の使いやすい携帯型フローサイトメトリーシステムや、特異性と感度を向上させる新規蛍光色素の開発が挙げられます。市場はダイナミックで競合情勢が特徴的であり、大手企業は研究開発に投資して進歩を推進し、競争上の優位性を獲得しています。コスト削減、使いやすさの向上、用途の拡大に引き続き注力することが、市場の成長を維持する上で極めて重要です。

市場力学：急速に進化する腫瘍学・免疫学におけるフローサイトメトリー市場の主要市場インサイトを公開

腫瘍学・免疫学におけるフローサイトメトリー市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的決定の精緻化、そして新たなビジネスチャンスの獲得に備えることができます。これらの動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができ、また、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • がんおよび免疫疾患の発生率の上昇
  • 個別化治療アプローチの開発の高まり
  • 免疫学および免疫腫瘍学研究分野における官民合同のイニシアチブの急増
• 市場抑制要因
  • 機器および試薬の高コスト
• 市場機会
  • 腫瘍学・免疫学のフローサイトメトリーにおけるマルチオミクスアプローチとの統合
  • フローサイトメトリー技術の小型化と進歩
• 市場の課題
  • 希少細胞の同定と特性解析の技術的難易度と相まって、規制とコンプライアンスの問題

ポーターのファイブフォース：腫瘍学・免疫学におけるフローサイトメトリー市場をナビゲートする戦略ツール

ポーターのファイブフォースフレームワークは、市場情勢の競合情勢を理解するための重要なツールです。ポーターのファイブフォース・フレームワークは、企業の競争力を評価し、戦略的機会を探るための明確な手法を提供します。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これらの洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することができ、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：腫瘍学・免疫学におけるフローサイトメトリー市場における外部からの影響の把握

外部マクロ環境要因は、腫瘍学・免疫学におけるフローサイトメトリー市場の業績ダイナミクスを形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を提供します。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析腫瘍学・免疫学におけるフローサイトメトリー市場における競合情勢の把握

腫瘍学・免疫学におけるフローサイトメトリー市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、断片化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニング・マトリックス腫瘍学・免疫学におけるフローサイトメトリー市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、腫瘍学・免疫学におけるフローサイトメトリー市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によりベンダーを明確かつ的確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨腫瘍学・免疫学におけるフローサイトメトリー市場における成功への道筋を描く

腫瘍学・免疫学におけるフローサイトメトリー市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を検討することで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネスチャンスを活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目分野を網羅した市場の包括的な分析を提供しています：

1.市場の浸透度：現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力の評価。

2.市場の開拓度：新興市場における成長機会を特定し、既存分野における拡大の可能性を評価し、将来の成長に向けた戦略的ロードマップを提供します。

3.市場の多様化：最近の製品発売、未開拓の地域、業界の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発およびイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています：

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、セグメント、地域はどこか？

3.市場を形成する主な技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • がんや免疫疾患の発生率の上昇
    • 個別化治療アプローチの開発の進展
    • 免疫学および免疫腫瘍学調査分野における官民連携の取り組みの急増
  • 抑制要因
    • 機器と試薬のコストが高い
  • 機会
    • 腫瘍学および免疫学のフローサイトメトリーにおけるマルチオミクスアプローチとの統合
    • フローサイトメトリー技術の小型化と進歩
  • 課題
    • 規制とコンプライアンスの問題と、希少細胞の特定と特性評価の技術的課題が組み合わさって
• 市場セグメンテーション分析
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治的
  • 経済
  • 社交
  • 技術的
  • 法律上
  • 環境

第6章 腫瘍学・免疫学におけるフローサイトメトリー市場：タイプ別

• 免疫学
• 腫瘍学

第7章 腫瘍学・免疫学におけるフローサイトメトリー市場：技術別

• ビーズベースのフローサイトメトリー
• 細胞ベースのフローサイトメトリー

第8章 腫瘍学・免疫学におけるフローサイトメトリー市場：製品・サービス別

• アクセサリー
• フローサイトメトリー機器
  • 細胞分析装置
  • 細胞選別装置
• 機器
• 試薬・消耗品
• サービス
• ソフトウェア

第9章 腫瘍学・免疫学におけるフローサイトメトリー市場：エンドユーザー別

• 学術調査機関
• 契約調査機関
• 病院、診断研究所
• 製薬・バイオテクノロジー企業

第10章 南北アメリカの腫瘍学・免疫学におけるフローサイトメトリー市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第11章 アジア太平洋地域の腫瘍学・免疫学におけるフローサイトメトリー市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第12章 欧州・中東・アフリカの腫瘍学・免疫学におけるフローサイトメトリー市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第13章 競合情勢

• 市場シェア分析2023
• FPNVポジショニングマトリックス, 2023
• 競合シナリオ分析
• 戦略分析と提言

企業一覧

• Agilent Technologies, Inc.
• Apogee Flow Systems Ltd.
• Becton, Dickinson and Company
• Bio-Rad Laboratories, Inc.
• bioMerieux SA
• Cytek Biosciences, Inc.
• Enzo Life Sciences, Inc.
• General Electric Company
• GenScript Biotech Corporation
• Merck KGaA
• Miltenyi Biotec B.V. & CO. KG
• Nanocellect Biomedical, Inc.
• Novozymes A/S
• On-Chip Biotechnologies Co., Ltd.
• RareCyte, Inc.
• Sartorius AG
• Sony Biotechnology Inc.
• Stratedigm, Inc.
• Sysmex Corporation
• Thermo Fisher Scientific, Inc.
• Union Biometrica, Inc.

LIST OF FIGURES

• FIGURE 1. FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET RESEARCH PROCESS
• FIGURE 2. FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY TECHNOLOGY, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY TECHNOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. GLOBAL FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY PRODUCT & SERVICE, 2023 VS 2030 (%)
• FIGURE 11. GLOBAL FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY PRODUCT & SERVICE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. GLOBAL FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY END USER, 2023 VS 2030 (%)
• FIGURE 13. GLOBAL FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. AMERICAS FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 15. AMERICAS FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. UNITED STATES FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 17. UNITED STATES FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. ASIA-PACIFIC FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 19. ASIA-PACIFIC FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 20. EUROPE, MIDDLE EAST & AFRICA FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 21. EUROPE, MIDDLE EAST & AFRICA FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 22. FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 23. FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET DYNAMICS
• TABLE 7. GLOBAL FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY IMMUNOLOGY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY BEAD-BASED FLOW CYTOMETRY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY CELL-BASED FLOW CYTOMETRY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY ACCESSORIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY FLOW CYTOMETRY INSTRUMENTS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY CELL ANALYZERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY CELL SORTERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 18. GLOBAL FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY FLOW CYTOMETRY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 19. GLOBAL FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 20. GLOBAL FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY REAGENTS & CONSUMABLES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 21. GLOBAL FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY SERVICES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 22. GLOBAL FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY SOFTWARE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 23. GLOBAL FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 24. GLOBAL FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 25. GLOBAL FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 26. GLOBAL FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY HOSPITALS, DIAGNOSTIC LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 27. GLOBAL FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 28. AMERICAS FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 29. AMERICAS FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 30. AMERICAS FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 31. AMERICAS FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY FLOW CYTOMETRY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 32. AMERICAS FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 33. AMERICAS FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 34. ARGENTINA FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 35. ARGENTINA FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 36. ARGENTINA FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 37. ARGENTINA FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY FLOW CYTOMETRY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 38. ARGENTINA FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 39. BRAZIL FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 40. BRAZIL FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 41. BRAZIL FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 42. BRAZIL FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY FLOW CYTOMETRY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 43. BRAZIL FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 44. CANADA FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 45. CANADA FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 46. CANADA FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 47. CANADA FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY FLOW CYTOMETRY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 48. CANADA FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 49. MEXICO FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 50. MEXICO FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 51. MEXICO FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 52. MEXICO FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY FLOW CYTOMETRY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 53. MEXICO FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 54. UNITED STATES FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 55. UNITED STATES FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 56. UNITED STATES FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 57. UNITED STATES FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY FLOW CYTOMETRY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 58. UNITED STATES FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 59. UNITED STATES FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 60. ASIA-PACIFIC FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 61. ASIA-PACIFIC FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 62. ASIA-PACIFIC FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 63. ASIA-PACIFIC FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY FLOW CYTOMETRY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 64. ASIA-PACIFIC FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 65. ASIA-PACIFIC FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 66. AUSTRALIA FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 67. AUSTRALIA FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 68. AUSTRALIA FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 69. AUSTRALIA FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY FLOW CYTOMETRY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 70. AUSTRALIA FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 71. CHINA FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 72. CHINA FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 73. CHINA FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 74. CHINA FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY FLOW CYTOMETRY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 75. CHINA FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 76. INDIA FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 77. INDIA FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 78. INDIA FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 79. INDIA FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY FLOW CYTOMETRY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 80. INDIA FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 81. INDONESIA FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 82. INDONESIA FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 83. INDONESIA FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 84. INDONESIA FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY FLOW CYTOMETRY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 85. INDONESIA FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 86. JAPAN FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 87. JAPAN FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 88. JAPAN FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 89. JAPAN FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY FLOW CYTOMETRY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 90. JAPAN FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 91. MALAYSIA FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 92. MALAYSIA FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 93. MALAYSIA FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 94. MALAYSIA FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY FLOW CYTOMETRY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 95. MALAYSIA FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 96. PHILIPPINES FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 97. PHILIPPINES FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 98. PHILIPPINES FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 99. PHILIPPINES FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY FLOW CYTOMETRY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 100. PHILIPPINES FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 101. SINGAPORE FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 102. SINGAPORE FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 103. SINGAPORE FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 104. SINGAPORE FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY FLOW CYTOMETRY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 105. SINGAPORE FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 106. SOUTH KOREA FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 107. SOUTH KOREA FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 108. SOUTH KOREA FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 109. SOUTH KOREA FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY FLOW CYTOMETRY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 110. SOUTH KOREA FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 111. TAIWAN FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 112. TAIWAN FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 113. TAIWAN FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 114. TAIWAN FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY FLOW CYTOMETRY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 115. TAIWAN FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 116. THAILAND FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 117. THAILAND FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 118. THAILAND FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 119. THAILAND FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY FLOW CYTOMETRY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 120. THAILAND FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 121. VIETNAM FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 122. VIETNAM FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 123. VIETNAM FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 124. VIETNAM FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY FLOW CYTOMETRY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 125. VIETNAM FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 126. EUROPE, MIDDLE EAST & AFRICA FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 127. EUROPE, MIDDLE EAST & AFRICA FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 128. EUROPE, MIDDLE EAST & AFRICA FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 129. EUROPE, MIDDLE EAST & AFRICA FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY FLOW CYTOMETRY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 130. EUROPE, MIDDLE EAST & AFRICA FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 131. EUROPE, MIDDLE EAST & AFRICA FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 132. DENMARK FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 133. DENMARK FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 134. DENMARK FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 135. DENMARK FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY FLOW CYTOMETRY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 136. DENMARK FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 137. EGYPT FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 138. EGYPT FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 139. EGYPT FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 140. EGYPT FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY FLOW CYTOMETRY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 141. EGYPT FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 142. FINLAND FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 143. FINLAND FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 144. FINLAND FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 145. FINLAND FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY FLOW CYTOMETRY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 146. FINLAND FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 147. FRANCE FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 148. FRANCE FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 149. FRANCE FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 150. FRANCE FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY FLOW CYTOMETRY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 151. FRANCE FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 152. GERMANY FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 153. GERMANY FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 154. GERMANY FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 155. GERMANY FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY FLOW CYTOMETRY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 156. GERMANY FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 157. ISRAEL FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 158. ISRAEL FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 159. ISRAEL FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 160. ISRAEL FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY FLOW CYTOMETRY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 161. ISRAEL FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 162. ITALY FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 163. ITALY FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 164. ITALY FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 165. ITALY FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY FLOW CYTOMETRY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 166. ITALY FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 167. NETHERLANDS FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 168. NETHERLANDS FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 169. NETHERLANDS FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 170. NETHERLANDS FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY FLOW CYTOMETRY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 171. NETHERLANDS FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 172. NIGERIA FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 173. NIGERIA FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 174. NIGERIA FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 175. NIGERIA FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY FLOW CYTOMETRY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 176. NIGERIA FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 177. NORWAY FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 178. NORWAY FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 179. NORWAY FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 180. NORWAY FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY FLOW CYTOMETRY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 181. NORWAY FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 182. POLAND FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 183. POLAND FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 184. POLAND FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 185. POLAND FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY FLOW CYTOMETRY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 186. POLAND FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 187. QATAR FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 188. QATAR FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 189. QATAR FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 190. QATAR FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY FLOW CYTOMETRY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 191. QATAR FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 192. RUSSIA FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 193. RUSSIA FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 194. RUSSIA FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 195. RUSSIA FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY FLOW CYTOMETRY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 196. RUSSIA FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 197. SAUDI ARABIA FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 198. SAUDI ARABIA FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 199. SAUDI ARABIA FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 200. SAUDI ARABIA FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY FLOW CYTOMETRY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 201. SAUDI ARABIA FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 202. SOUTH AFRICA FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 203. SOUTH AFRICA FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 204. SOUTH AFRICA FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 205. SOUTH AFRICA FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY FLOW CYTOMETRY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 206. SOUTH AFRICA FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 207. SPAIN FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 208. SPAIN FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 209. SPAIN FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 210. SPAIN FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY FLOW CYTOMETRY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 211. SPAIN FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 212. SWEDEN FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 213. SWEDEN FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 214. SWEDEN FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 215. SWEDEN FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY FLOW CYTOMETRY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 216. SWEDEN FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 217. SWITZERLAND FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 218. SWITZERLAND FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 219. SWITZERLAND FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 220. SWITZERLAND FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY FLOW CYTOMETRY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 221. SWITZERLAND FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 222. TURKEY FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 223. TURKEY FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 224. TURKEY FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 225. TURKEY FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY FLOW CYTOMETRY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 226. TURKEY FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 227. UNITED ARAB EMIRATES FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 228. UNITED ARAB EMIRATES FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 229. UNITED ARAB EMIRATES FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 230. UNITED ARAB EMIRATES FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY FLOW CYTOMETRY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 231. UNITED ARAB EMIRATES FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 232. UNITED KINGDOM FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 233. UNITED KINGDOM FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 234. UNITED KINGDOM FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 235. UNITED KINGDOM FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY FLOW CYTOMETRY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 236. UNITED KINGDOM FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 237. FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 238. FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET, FPNV POSITIONING MATRIX, 2023

The Flow Cytometry in Oncology & Immunology Market was valued at USD 1.10 billion in 2023, expected to reach USD 1.18 billion in 2024, and is projected to grow at a CAGR of 9.33%, to USD 2.06 billion by 2030.

Flow cytometry is a powerful analytical technology extensively used in oncology and immunology for measuring the physical and chemical characteristics of cells or particles as they pass through a laser beam. The necessity of flow cytometry in these fields is underscored by its capability for rapid multiparametric analysis of the phenotypes and functions of heterogeneous cell populations, aiding in disease diagnosis, prognosis, and monitoring of therapeutic responses. Applications include immunophenotyping, cell sorting, cancer biomarker detection, and determining cell cycle status. The end-use scope spans clinical laboratories, academic research institutions, pharmaceutical companies, and diagnostic centers. The market growth is primarily influenced by the increasing prevalence of cancers and immune system disorders, advancements in flow cytometry technologies leading to enhanced accuracy and reduced time of analysis, and the expanding adoption of flow cytometry in novel applications like pharmacodynamics and drug target identification. Emerging opportunities lie in the integration of artificial intelligence for data analysis, which can enhance the speed and accuracy of flow cytometry results. Recommendations include capitalizing on technological upgrades, developing cost-effective systems for smaller labs, and expanding into untapped markets with growing healthcare infrastructure. However, limitations such as high costs of instruments and reagents, the requirement for skilled technicians, and regulatory constraints pose challenges to market proliferation. Standardization across labs to ensure data comparability is another challenge facing researchers and clinicians. The best areas for innovation and research include the development of user-friendly, portable flow cytometry systems for point-of-care diagnostics, and novel fluorochromes to improve specificity and sensitivity. The market is characterized by a dynamic and competitive landscape, with major players investing in R&D to drive advancements and gain competitive advantage. Continued focus on cost reduction, enhanced usability, and broadening applications will be pivotal for sustaining market growth.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Flow Cytometry in Oncology & Immunology Market

The Flow Cytometry in Oncology & Immunology Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Rising Incidence of cancer and immunological disorders
  • Growing development of personalized treatment approaches
  • Surging public-private initiatives in the field of immunology and immune-oncology research
• Market Restraints
  • High Cost of equipment and reagents
• Market Opportunities
  • Integration with multi-omics approaches in flow cytometry for oncology & immunology
  • Miniaturization and advancements in flow cytometry technology
• Market Challenges
  • Regulatory and compliance issues coupled with technically challenging for identifying and characterizing rare cell

Porter's Five Forces: A Strategic Tool for Navigating the Flow Cytometry in Oncology & Immunology Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Flow Cytometry in Oncology & Immunology Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Flow Cytometry in Oncology & Immunology Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Flow Cytometry in Oncology & Immunology Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Flow Cytometry in Oncology & Immunology Market

A detailed market share analysis in the Flow Cytometry in Oncology & Immunology Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Flow Cytometry in Oncology & Immunology Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Flow Cytometry in Oncology & Immunology Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Flow Cytometry in Oncology & Immunology Market

A strategic analysis of the Flow Cytometry in Oncology & Immunology Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Flow Cytometry in Oncology & Immunology Market, highlighting leading vendors and their innovative profiles. These include Agilent Technologies, Inc., Apogee Flow Systems Ltd., Becton, Dickinson and Company, Bio-Rad Laboratories, Inc., bioMerieux SA, Cytek Biosciences, Inc., Enzo Life Sciences, Inc., General Electric Company, GenScript Biotech Corporation, Merck KGaA, Miltenyi Biotec B.V. & CO. KG, Nanocellect Biomedical, Inc., Novozymes A/S, On-Chip Biotechnologies Co., Ltd., RareCyte, Inc., Sartorius AG, Sony Biotechnology Inc., Stratedigm, Inc., Sysmex Corporation, Thermo Fisher Scientific, Inc., and Union Biometrica, Inc..

Market Segmentation & Coverage

This research report categorizes the Flow Cytometry in Oncology & Immunology Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Type, market is studied across Immunology and Oncology.
• Based on Technology, market is studied across Bead-based Flow Cytometry and Cell-based Flow Cytometry.
• Based on Product & Service, market is studied across Accessories, Flow Cytometry Instruments, Instruments, Reagents & Consumables, Services, and Software. The Flow Cytometry Instruments is further studied across Cell Analyzers and Cell Sorters.
• Based on End User, market is studied across Academic Research Institutes, Contract Research Organizations, Hospitals, Diagnostic Laboratories, and Pharmaceutical & Biotechnology Companies.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Rising Incidence of cancer and immunological disorders
    • 5.1.1.2. Growing development of personalized treatment approaches
    • 5.1.1.3. Surging public-private initiatives in the field of immunology and immune-oncology research
  • 5.1.2. Restraints
    • 5.1.2.1. High Cost of equipment and reagents
  • 5.1.3. Opportunities
    • 5.1.3.1. Integration with multi-omics approaches in flow cytometry for oncology & immunology
    • 5.1.3.2. Miniaturization and advancements in flow cytometry technology
  • 5.1.4. Challenges
    • 5.1.4.1. Regulatory and compliance issues coupled with technically challenging for identifying and characterizing rare cell
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Flow Cytometry in Oncology & Immunology Market, by Type

• 6.1. Introduction
• 6.2. Immunology
• 6.3. Oncology

7. Flow Cytometry in Oncology & Immunology Market, by Technology

• 7.1. Introduction
• 7.2. Bead-based Flow Cytometry
• 7.3. Cell-based Flow Cytometry

8. Flow Cytometry in Oncology & Immunology Market, by Product & Service

• 8.1. Introduction
• 8.2. Accessories
• 8.3. Flow Cytometry Instruments
  • 8.3.1. Cell Analyzers
  • 8.3.2. Cell Sorters
• 8.4. Instruments
• 8.5. Reagents & Consumables
• 8.6. Services
• 8.7. Software

9. Flow Cytometry in Oncology & Immunology Market, by End User

• 9.1. Introduction
• 9.2. Academic Research Institutes
• 9.3. Contract Research Organizations
• 9.4. Hospitals, Diagnostic Laboratories
• 9.5. Pharmaceutical & Biotechnology Companies

10. Americas Flow Cytometry in Oncology & Immunology Market

• 10.1. Introduction
• 10.2. Argentina
• 10.3. Brazil
• 10.4. Canada
• 10.5. Mexico
• 10.6. United States

11. Asia-Pacific Flow Cytometry in Oncology & Immunology Market

• 11.1. Introduction
• 11.2. Australia
• 11.3. China
• 11.4. India
• 11.5. Indonesia
• 11.6. Japan
• 11.7. Malaysia
• 11.8. Philippines
• 11.9. Singapore
• 11.10. South Korea
• 11.11. Taiwan
• 11.12. Thailand
• 11.13. Vietnam

12. Europe, Middle East & Africa Flow Cytometry in Oncology & Immunology Market

• 12.1. Introduction
• 12.2. Denmark
• 12.3. Egypt
• 12.4. Finland
• 12.5. France
• 12.6. Germany
• 12.7. Israel
• 12.8. Italy
• 12.9. Netherlands
• 12.10. Nigeria
• 12.11. Norway
• 12.12. Poland
• 12.13. Qatar
• 12.14. Russia
• 12.15. Saudi Arabia
• 12.16. South Africa
• 12.17. Spain
• 12.18. Sweden
• 12.19. Switzerland
• 12.20. Turkey
• 12.21. United Arab Emirates
• 12.22. United Kingdom

13. Competitive Landscape

• 13.1. Market Share Analysis, 2023
• 13.2. FPNV Positioning Matrix, 2023
• 13.3. Competitive Scenario Analysis
• 13.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Agilent Technologies, Inc.
• 2. Apogee Flow Systems Ltd.
• 3. Becton, Dickinson and Company
• 4. Bio-Rad Laboratories, Inc.
• 5. bioMerieux SA
• 6. Cytek Biosciences, Inc.
• 7. Enzo Life Sciences, Inc.
• 8. General Electric Company
• 9. GenScript Biotech Corporation
• 10. Merck KGaA
• 11. Miltenyi Biotec B.V. & CO. KG
• 12. Nanocellect Biomedical, Inc.
• 13. Novozymes A/S
• 14. On-Chip Biotechnologies Co., Ltd.
• 15. RareCyte, Inc.
• 16. Sartorius AG
• 17. Sony Biotechnology Inc.
• 18. Stratedigm, Inc.
• 19. Sysmex Corporation
• 20. Thermo Fisher Scientific, Inc.
• 21. Union Biometrica, Inc.